ADMA Biologics Inc (ADMA NASDAQ) stock market data APIs
$16.67
0.35(2.1%)
as of January 14, 2025
ADMA Biologics Inc Financial Data Overview
Price chart is built with
Anychart
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
Prev. Close
16.32
Open
16.67
Volume
2 711 K
High
16.755
Low
15.92
52 wk Range
4.8605-23.64
Market Cap
3 858 M
P/E Ratio
60.4444
Shares Outstanding
236 M
Revenue
383 M
EPS
0.15
Beta
0.645
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ADMA Biologics Inc data using free add-ons & libraries
Get ADMA Biologics Inc Fundamental Data
ADMA Biologics Inc Fundamental data includes:
- Net Revenue: 383 M
- EBITDA: 126 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-11-07
- EPS/Forecast: 0.13
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ADMA Biologics Inc News
New
CVS Has 'Real Value,' Jim Cramer Says: Micron Had An 'Amazing' Quarter
CVS Has 'Real Value,' Jim Cramer Says: Micron Had An 'Amazing' Quarter Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. When asked about CVS Healt...
Is ADMA Biologics Inc. (ADMA) the Best Performing Small-Cap Stock in 2024?
We recently compiled a list of the 10 Best Performing Small-Cap Stocks in 2024. In this article, we will look at where ADMA Biologics Inc. (NASDAQ:ADMA) ranks among the best-performing small-cap stock...
3 Millionaire-Making Stock Picks With Astounding Growth Potential
Finding millionaire-making stocks is not easy. While we can’t tell the future, we can do the next best thing: think forward, gauge a company’s room for growth, and determine how it intends to reac...
ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD
RAMSEY, N.J. and BOCA RATON, Fla. and LAUREL, Md., Nov. 16, 2023 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
